Ryan Varghese is a researcher affiliated with the Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, and Philadelphia, USA. His work spans a spectrum of topics from artificial intelligence to cancer theranostics and drug delivery in Alzheimer's disease. His specialization lies in the drug delivery modalities in chronic diseases. He has curated several articles on the lacunae in the Government’s public policies while providing solutions for the same. His recent work included the proposal on drug repurposing and affordable hospitalization to mitigate the risk stemming from COVID-19 in India. His current line of work lies in the efficient diagnosis and treatment of various cancers.
Rushil Dalal is a researcher currently affiliated with the Ludwig-Maximilians-Universität München. With a formal education in Biotechnology, his current lines of work encompass the development of novel therapeutics for oncological malignancies. Previously, he was associated with the Tata Memorial Centre - Advanced Centre for Treatment, Research and Education in Cancer (TMC-ACTREC). During his tenure, he has contributed significantly to the Department of Clinical Pharmacology, with his research in oncogenomics, where he was on the quest to elucidate SNPs that amplified the occurrence of tobacco-related head and neck cancer.
Jainam Karsiya is a clinical pharmacist and medical affairs executive associated with RiverRoute Creative Group, India. His domain of work expands across the length and breadth of oncology, ranging from drug delivery and clinical therapeutics to precision oncology. He has prior experience in nanotechnology, theranostics, and health outcomes research. He has also contributed to the drafting of public policies in the healthcare sector.
Dileep Kumar is an associate professor in the Department of Pharmaceutical Chemistry at Poona College of Pharmacy. He is a pioneer in his field with his forte in the treatment and novel drug delivery in Cancer and Alzheimer’s disease, especially adamantyl analogs as GluN2B selective NMDA receptor agonists. He is also an awardee of the Junior Research Fellowship from the National Medicinal Plant Board (NMPB) New Delhi, a Senior Research Fellowship from the University Grants Commission (UGC), a Teaching Assistantship, and an Institute Post-Doctoral Fellowship from IIT (BHU) Varanasi. He is the Guest Editor of prestigious journals like Current Topics in Medicinal Chemistry, Current Drug Target, combinatorial chemistry, and Molecules.
.jpg "Juris Hmelnickis")
.jpg "Eiman Shafa")
